Immunotherapy for hepatocellular carcinoma: Current and future

doi:10.3748/wjg.v25.i24.2977

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 24

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (16322)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

1559

WORD

251

HTML

12095

Figures (1-1)

261

Tables (1-1)

222

Sum=14388

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

837

Download

1097

Sum=1934

Jun 28, 2019 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (135)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jun 28, 2019; 25(24): 2977-2989
Published online Jun 28, 2019. doi: 10.3748/wjg.v25.i24.2977

Open in New Tab Full Size Figure Download Figure

Figure 1 Current approaches of immunotherapy. Summary of immunotherapeutic agents studied in hepatocellular carcinoma. CAR-T: Chimeric antigen receptor expressing T cell; CIK: Cytokine-induced killer; CTLA-4: Cytotoxic T-lymphocyte associated antigen 4; DC: Dendritic cell; LAG-3: Lymphocyte activation gene 3; NK: Natural killer; PD-1: Programmed cell death protein 1; TGF-β: Transforming growth factor-β; Tim-3: T-cell immunoglobulin and mucin-domain containing-3. ¹Licensed by Food and Drug Administration.

Citation: Johnston MP, Khakoo SI. Immunotherapy for hepatocellular carcinoma: Current and future. World J Gastroenterol 2019; 25(24): 2977-2989
URL: https://www.wjgnet.com/1007-9327/full/v25/i24/2977.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i24.2977